Navigation Links
HIPAA 5010 Ready: DST Health Solutions Launches Upgrades of Amisys Advance, PowerMHS, PowerMHC and PowerSTEPP
Date:11/8/2010

BIRMINGHAM, Ala., Nov. 8, 2010 /PRNewswire/ -- DST Health Solutions, LLC, today launched new versions of all four of its core claims administration platforms—Amisys Advance, PowerMHC, PowerMHS and PowerSTEPP. The platforms now support Version 5010, as mandated by the Centers for Medicare & Medicaid Services (CMS). This change—from Version 4010/4010A to Version 5010 of the electronic healthcare transaction standard—will be effective Jan. 1, 2012, as designated by CMS.

These upgrades are a significant part of DST Health Solutions' 5-I Compliance Accelerator Program, designed to help health plans successfully prepare major business systems for compliance with upcoming federal regulations. Within two years, CMS will require healthcare organizations to begin using the new 5010 standards for electronic transactions and within three years upgrade from ICD-9 to ICD-10, a new diagnostic and procedure code set. This transition has been called "healthcare's Y2K."

"Medical Card System, Inc. (MCS) has been tracking these regulatory changes for some time now, and it was clear that we required professional advice," said Ivars Blums, chief information officer of MCS, a Puerto Rico-based health plan and DST Health Solutions client. "DST Health Solutions' consultants have enabled my IT staff to analyze and prepare our PowerMHS environment for a successful transition to 5010 and ICD-10. We know that PowerMHS is fully capable of supporting our goal: to turn these regulations into opportunities to move forward and improve administrative efficiency and quality of care."

The majority of DST Health Solutions' clients are participating in its 5-I Compliance Accelerator Program. Participating clients include health plans utilizing all four of the company's core claims platforms. The program includes assessment services, migration support packages, business impact consulting, readiness roadmaps, transaction maps and supplemental resources to suppo
'/>"/>

SOURCE DST Health Solutions, LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Monterey Spine and Joint Deploys WebLOQ ePrivacy Solution for HIPAA Compliant Health Information Exchange
2. Health Robotics Continues Worldwide Consolidation by Entering the Norwegian Market With Beckman Automation
3. Hikma Expands its Global Injectables Business Through the Acquisition of Baxter Healthcare Corporations Multi-Source Injectables Business
4. Midwest Health Care Startups Raise $572 Million Through Q3 2010
5. Beckman Coulter to Present at the Oppenheimer 21st Annual Healthcare Conference
6. Ardea Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
7. Regado Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference in New York City
8. Genomic Health to Announce Third Quarter 2010 Financial Results and Host Conference Call on Monday, November 8, 2010
9. Optimer Pharmaceuticals to Present at Oppenheimer Healthcare Conference
10. Todd Park, Chief Technology Officer of U.S. Department of Health and Human Services, Joins Opening Keynote Line-Up at 2010 mHealth Summit
11. Genesis Biopharma to Present at the Informed Investors Forum Biotech, Healthcare & Pharma Virtual Conference on October 13
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Philadelphia, PA (PRWEB) June 18, 2013 ... fiber-optic Ball Lenses engineered of synthetic Sapphire and Glass ... stock sizes from Swiss Jewel Company , of ... performance by expanding and collimating the light beams without ... extreme optical clarity and natural durability (9 mohs) make ...
(Date:6/18/2013)... , June 18, 2013 ... the release of the HELM biomolecular representation standard ... source MIT licence. HELM (Hierarchical Editing ... wide range of biomolecules (e.g. proteins, nucleotides, antibody ... small-molecule and sequence-based informatics methodologies impractical or unusable. ...
(Date:6/18/2013)... Israel , June 18, 2013 ... Active Pharmaceutical Ingredients (APIs), generic and innovative intermediates, and finished ... that the company has been granted a United ... the US and Europe for the ... number 8,410,176 B2 is titled Intermediate Compounds and Processes ...
(Date:6/18/2013)... 2013   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... on discovering breakthrough treatments for human disease, announced ... the company as its vice president of marketing, ... commercial experience to Lexicon, including both pre-launch planning ... areas. Mr. Northcott has held commercial ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2The Pistoia Alliance Releases HELM Biomolecular Representation Standard Open Source Tools 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 2John Northcott Joins Lexicon as Vice President of Marketing, Commercial Strategy and Operations 3
... NEW YORK, June 5 Crystal Research Associates, ... Informational Overview(R),(EIO(R)) on Arana Therapeutics Ltd. (AAH: ASX). ... http://www.crystalra.com ., Arana Therapeutics Ltd. ("Arana" ... antibody therapeutics to treat,inflammatory diseases and cancer. Arana,s ...
... American Oriental,Bioengineering (NYSE: AOB ) announced today ... The decision to cancel its,convertible preferred stock offering ... conditions resulting in terms that were not acceptable ... Statements made in this press release are forward-looking ...
... Calif., June 5 Exelixis,Inc. (Nasdaq: EXEL ) ... with Deerfield Management, a leading healthcare investment,organization and significant ... in financing through a flexible credit facility. The,funds can ... months at Exelixis,discretion. Exelixis is under no obligation to ...
Cached Biology Technology:Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 2Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Arana Therapeutics Ltd. 3Exelixis Receives $150 Million Funding Commitment From Deerfield Management 2Exelixis Receives $150 Million Funding Commitment From Deerfield Management 3Exelixis Receives $150 Million Funding Commitment From Deerfield Management 4Exelixis Receives $150 Million Funding Commitment From Deerfield Management 5
(Date:6/17/2013)... State University research associate has received a prestigious fellowship ... prevent the spread of malaria. , Bart Bryant, research ... Health,s National Research Service Award Individual Postdoctoral Fellowship, which ... Kansas State University researcher to receive the award and ... such an award. , Bryant, a university doctoral graduate ...
(Date:6/17/2013)... French . A ... Alzheimer,s disease can be reversed with treatment. The study by ... Neuro, at McGill University and at Universit de Montral found ... brain of mice with advanced Alzheimer,s disease (AD) recovers memory ... of Neuroinflammation in May, also suggest an underlying mechanism ...
(Date:6/15/2013)... -- A drug approved in Europe to treat osteoporosis ... breast cancer cells, even in cancers that have become ... Cancer Institute study. , The findings, presented June 15, ... Francisco, indicate that the drug bazedoxifene packs a powerful ... breast cancer cell growth, but also flags the estrogen ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2Blocking overactive receptor in Alzheimer's recovers memory loss and more 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... federal government will spend $21 billion for HIV/AIDS research, ... paying off? A study published in the July 1 ... online, indicates that it is--and more so than previously ... MPH, Kenneth Freedberg , MD, MSc and colleagues at ...
... and ferrets against a highly lethal avian influenza virus, ... St. Jude Children's Research Hospital. The vaccine was developed ... finding, coupled with results of previous studies that showed ... a vaccine would protect humans against multiple variants of ...
... water cycle and havens for wildlife, but they ... collaboration with the Ramsar Convention Secretariat, has been ... provide detailed wide-area views of individual wetlands to ... the success of wetland conservation ultimately comes down ...
Cached Biology News:New study calculates millions of years saved in lives of AIDS patients 2St. Jude test of bird flu vaccine proves successful 2African wetland managers armed with new technology 2
... PCR Workstation brings together UV irradiation and ... environment against PCR contamination! Quickly inactivate ... Maintain a clean environment with antimicrobial coated ... reagents within minutes with built-in 30-minute timer ...
... Recombinant Enterokinase (rEK) is a highly purified ... enterokinase, a serine protease which recognizes the ... (AspAspAspAspLys?) and has similar enzymatic activity (1). ... and purified to yield the highest activity ...
... of a Hybridizer and UV Crosslinker (254nm UV) ... , This unique, new design for the ... one location , Hybridizer and Crosslinker portions ... , The Crosslinker is also available as ...
Preparation Note: Prepared essentially by method of Singer, T.P., J. Biol. Chem., 174, 11 (1948). Quality Clarifier: Contains lipase Unit Definition: One unit will hydrolyze 1.0 μmole of p-ni...
Biology Products: